Nowadays, nanotechnology has been considered as a potential tool for the development of new drug delivery systems, such as nanoparticles. Although, before these approaches can be considered as anti-tumoral treatments, they need to be thoroughly tested under high controlled conditions that reproduce the tumors microenvironment. In vivo, tumors are complex tissues comprised by cancer cells enclosed in a stroma, essentially formed by fibroblasts.